NanJing Pharmaceutical Company Limited reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 11,700.6 million compared to CNY 11,084.76 million a year ago. Revenue was CNY 11,700.6 million compared to CNY 11,084.76 million a year ago. Net income was CNY 132.55 million compared to CNY 101.96 million a year ago. Basic earnings per share from continuing operations was CNY 0.112 compared to CNY 0.098 a year ago. Diluted earnings per share from continuing operations was CNY 0.112 compared to CNY 0.098 a year ago.